Potassium Carbonate → HCID 46867019, 화합물

HRID 1689884노트

반응식

HRID 1689884 반응식
[C:1]([N:8]1[CH2:13][CH2:12][NH:11][CH2:10][CH2:9]1)([O:3][C:4]([CH3:7])([CH3:6])[CH3:5])=[O:2].C(=O)([O-])[O-].[K+].[K+].[CH3:20][C:21]1[O:25][N:24]=[C:23]([CH2:26]OS(C)(=O)=O)[CH:22]=1>CC#N.O>[C:4]([O:3][C:1]([N:8]1[CH2:9][CH2:10][N:11]([CH2:26][C:23]2[CH:22]=[C:21]([CH3:20])[O:25][N:24]=2)[CH2:12][CH2:13]1)=[O:2])([CH3:7])([CH3:6])[CH3:5]

참가 물질

6

반응물 3

HCID 11430Potassium CarbonateHCID 143452tert-Butyl piperazine-1-carboxylateHCID 57476926Methanesulfonic acid 5-methyl-isoxazol-3-ylmethyl ester

생성물 1

HCID 46867019HCID 46867019, 화합물수율 89.1%

시약·촉매·용매 2

HCID 962Water용매HCID 6342Acetonitrile용매

실험 절차

To a solution of N—BOC-piperazine (300 mg) in MeCN (5 mL) was added potassium carbonate (289 mg) followed by methanesulfonic acid 5-methyl-isoxazol-3-ylmethyl ester (369 mg). The reaction mixture was heated to reflux for 24 h. After cooling the reaction mixture was diluted with water, extracted into ethyl acetate, dried (MgSO4) and the solvent was removed in vacuo to yield 4-(5-methyl-isoxazol-3-ylmethyl)-piperazine-1-carboxylic acid tert-butyl ester (404 mg).

후처리

  1. temperatureThe reaction mixture was heated
  2. temperatureto reflux for 24 h
  3. temperatureAfter cooling the reaction mixture
  4. extractionextracted into ethyl acetate
  5. dry with materialdried (MgSO4)
  6. customthe solvent was removed in vacuo

출처 및 근거

ORD 기록
ord-bab7f3ee5a124b4aaa179b97b3e2225f
출처 데이터셋
uspto-grants-2012_04
특허 번호
US08153629B2

반응 노트

불러오는 중…